Biotech / Pharma
Hengrui Pharma
Biotech / Pharma
Novo Nordisk licenses weight-loss treatment from Chinese pharma firm Hengrui Pharma, underscoring China's advancing biotech capabilities and international collaboration.
Founded
Region
Investors
People